LAUREN HAYSLETTE: Open Payments
NPI 1124619523 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,511 in 121 payments from 20 companies in 2025. Trend: 2023 $1,821 · 2024 $1,890 · 2025 $2,511
Food & beverage: $2,285Education: $226
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $429 |
| Regeneron Healthcare Solutions, Inc. | 27 | $391 |
| GlaxoSmithKline, LLC. | 13 | $322 |
| GENZYME CORPORATION | 17 | $222 |
| Grifols USA, LLC | 7 | $191 |
| Viatris Specialty LLC | 12 | $183 |
| SANOFI-AVENTIS U.S. LLC | 2 | $183 |
| Verona Pharma, Inc. | 4 | $81 |
| Actelion Pharmaceuticals US, Inc. | 3 | $71 |
| HARMONY BIOSCIENCES LLC | 2 | $61 |
Products named: DUPIXENT, FASENRA, NUCALA, Prolastin-C Liquid, YUPELRI, TEZSPIRE, Ohtuvayre, WAKIX.
Industry payments across MI — which companies pay providers there.
